[go: up one dir, main page]

WO2009026133A3 - Transdermal bisoprolol delivery system - Google Patents

Transdermal bisoprolol delivery system Download PDF

Info

Publication number
WO2009026133A3
WO2009026133A3 PCT/US2008/073270 US2008073270W WO2009026133A3 WO 2009026133 A3 WO2009026133 A3 WO 2009026133A3 US 2008073270 W US2008073270 W US 2008073270W WO 2009026133 A3 WO2009026133 A3 WO 2009026133A3
Authority
WO
WIPO (PCT)
Prior art keywords
bisoprolol
transdermal
delivery system
delivery
rate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/073270
Other languages
French (fr)
Other versions
WO2009026133A2 (en
Inventor
Jianye Wen
Sangita Ghosh
Delphine Imbert
Tyler D. Westcott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of WO2009026133A2 publication Critical patent/WO2009026133A2/en
Anticipated expiration legal-status Critical
Publication of WO2009026133A3 publication Critical patent/WO2009026133A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A transdermal bisoprolol delivery system to an individual in need thereof. The system includes a backing layer, a reservoir disposed proximally relative to the backing layer. The reservoir has a polymeric composition containing an amount of bisoprolol or a pharmaceutically acceptable salt thereof sufficient for multiple-day delivery. The system can have a rate-control layer to control the rate of bisoprolol delivery to the user.
PCT/US2008/073270 2007-08-17 2008-08-15 Transdermal bisoprolol delivery system Ceased WO2009026133A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96507907P 2007-08-17 2007-08-17
US60/965,079 2007-08-17

Publications (2)

Publication Number Publication Date
WO2009026133A2 WO2009026133A2 (en) 2009-02-26
WO2009026133A3 true WO2009026133A3 (en) 2010-04-01

Family

ID=39769545

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/073270 Ceased WO2009026133A2 (en) 2007-08-17 2008-08-15 Transdermal bisoprolol delivery system

Country Status (1)

Country Link
WO (1) WO2009026133A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5758290B2 (en) * 2009-05-01 2015-08-05 久光製薬株式会社 Transdermal preparation

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005042055A2 (en) * 2003-10-28 2005-05-12 Noven Pharmaceuticals, Inc. Transdermal drug delivery device
US20060078604A1 (en) * 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
WO2006080199A1 (en) * 2005-01-31 2006-08-03 Hisamitsu Pharmaceutical Co., Inc. Patch
WO2007029781A1 (en) * 2005-09-09 2007-03-15 Nitto Denko Corporation Adhesive preparation containing bisoprolol
WO2007035939A2 (en) * 2005-09-23 2007-03-29 Alza Corporation High enhancer-loading polyacrylate formulation for transdermal applications
WO2007065303A1 (en) * 2005-12-09 2007-06-14 Beijing Kangbeide Pharmaceutical Technology Development Co., Ltd. Transdermal patch containing isosorbide dinitrate and bisoprolol

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005042055A2 (en) * 2003-10-28 2005-05-12 Noven Pharmaceuticals, Inc. Transdermal drug delivery device
US20060078604A1 (en) * 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
WO2006080199A1 (en) * 2005-01-31 2006-08-03 Hisamitsu Pharmaceutical Co., Inc. Patch
EP1847264A1 (en) * 2005-01-31 2007-10-24 Hisamitsu Pharmaceutical Co. Inc. Patch
WO2007029781A1 (en) * 2005-09-09 2007-03-15 Nitto Denko Corporation Adhesive preparation containing bisoprolol
EP1932523A1 (en) * 2005-09-09 2008-06-18 Nitto Denko Corporation Adhesive preparation containing bisoprolol
WO2007035939A2 (en) * 2005-09-23 2007-03-29 Alza Corporation High enhancer-loading polyacrylate formulation for transdermal applications
WO2007065303A1 (en) * 2005-12-09 2007-06-14 Beijing Kangbeide Pharmaceutical Technology Development Co., Ltd. Transdermal patch containing isosorbide dinitrate and bisoprolol
US20080292685A1 (en) * 2005-12-09 2008-11-27 Beijing Kangbeide Pharmaceutical Technology Development Co., Ltd Transdermal Patch Containing Isosorbide Dinitrate and Bisoprolol

Also Published As

Publication number Publication date
WO2009026133A2 (en) 2009-02-26

Similar Documents

Publication Publication Date Title
WO2008123625A1 (en) Method for activating receptor by cofactor and method for utilizing ligand activity
WO2011076621A3 (en) Transdermal therapeutic system for administering rivastigmine or derivatives thereof
IL180916A0 (en) Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
WO2006050221A3 (en) Porous photonic crystals for drug delivery to the eye
WO2006044206A3 (en) Transdermal drug delivery device including an occlusive backing
WO2011079001A3 (en) Anhydrous liquid antiperspirant/deodorant composition
WO2007094940A3 (en) Implantable medical device with surface-eroding polyester drug delivery coating
IL216704A0 (en) Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery
TW200616589A (en) Transdermal delivery of drugs based on crystal size
WO2008078318A3 (en) Systems and devices for sustained delivery of therapeutic fluid
WO2006041907A3 (en) Transdermal delivery of estradiol
WO2009032737A3 (en) Systems and methods for delivering medication
WO2012002640A3 (en) Transdermal drug delivery system containing donepezil
MX2009011357A (en) Tetrahydropyrido[4,3-d]pyrimidinone derivatives and methods of use thereof.
IL178499A0 (en) Transdermal delivery system for use with basic permeation enhancers
WO2009106831A3 (en) Pharmaceutical composition comprising naltrexone
WO2006047362A3 (en) Transdermal delivery systems
WO2009026135A3 (en) Controlled transdermal bisoprolol delivery system
IL194770A0 (en) 6-(4-cyclopropylpiperazin-1-yl)-2'-methyl-[3,4']-bipyridine and its use as a medicament
AU2003215657A1 (en) Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion.
HK1216503A1 (en) Compositions and methods for transdermal delivery of amphetamine
WO2005105110A3 (en) Doxepin analogs and methods of use thereof
WO2008156045A1 (en) Management system for prescribing/preparing medicine which may cause severe side effect
WO2007035941A3 (en) Transdermal galantamine delivery system
WO2009144551A3 (en) Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium level in the blood

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08797954

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 07/06/2010)

122 Ep: pct application non-entry in european phase

Ref document number: 08797954

Country of ref document: EP

Kind code of ref document: A2